Henin G, Loumaye A, Leclercq I, Lanthier N
JHEP Rep. 2024; 6(2):100963.
PMID: 38322420
PMC: 10844870.
DOI: 10.1016/j.jhepr.2023.100963.
Nelson A, Queathem E, Puchalska P, Crawford P
Nat Metab. 2023; 5(12):2062-2074.
PMID: 38092961
DOI: 10.1038/s42255-023-00935-3.
Fu X, Fletcher J, Deja S, Inigo-Vollmer M, Burgess S, Browning J
J Clin Invest. 2023; 133(9).
PMID: 36928190
PMC: 10145942.
DOI: 10.1172/JCI167442.
Alnami A, Bima A, Alamoudi A, Eldakhakhny B, Sakr H, Elsamanoudy A
Nutrients. 2022; 14(9).
PMID: 35565871
PMC: 9102123.
DOI: 10.3390/nu14091903.
Mazloomi S, Samadi M, Davarpanah H, Babajafari S, Clark C, Ghaemfar Z
Food Sci Nutr. 2022; 10(2):317-328.
PMID: 35154670
PMC: 8825726.
DOI: 10.1002/fsn3.2368.
β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.
Mey J, Erickson M, Axelrod C, King W, Flask C, McCullough A
Am J Physiol Endocrinol Metab. 2020; 319(1):E187-E195.
PMID: 32396388
PMC: 7468782.
DOI: 10.1152/ajpendo.00058.2020.
Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.
Luukkonen P, Dufour S, Lyu K, Zhang X, Hakkarainen A, Lehtimaki T
Proc Natl Acad Sci U S A. 2020; 117(13):7347-7354.
PMID: 32179679
PMC: 7132133.
DOI: 10.1073/pnas.1922344117.
Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes.
Reginato E, Pippi R, Aiello C, Sbroma Tomaro E, Ranucci C, Buratta L
J Clin Med. 2019; 8(6).
PMID: 31207986
PMC: 6616932.
DOI: 10.3390/jcm8060851.
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.
Fletcher J, Deja S, Satapati S, Fu X, Burgess S, Browning J
JCI Insight. 2019; 5.
PMID: 31012869
PMC: 6629163.
DOI: 10.1172/jci.insight.127737.
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.
Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Rasanen S
Cell Metab. 2018; 27(3):559-571.e5.
PMID: 29456073
PMC: 6706084.
DOI: 10.1016/j.cmet.2018.01.005.
Endocrine causes of nonalcoholic fatty liver disease.
Marino L, Jornayvaz F
World J Gastroenterol. 2015; 21(39):11053-76.
PMID: 26494962
PMC: 4607905.
DOI: 10.3748/wjg.v21.i39.11053.
The hepatoprotective and hypolipidemic effects of Spirulina () supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.
Mazokopakis E, Papadomanolaki M, Fousteris A, Kotsiris D, Lampadakis I, Ganotakis E
Ann Gastroenterol. 2014; 27(4):387-394.
PMID: 25331487
PMC: 4188938.
Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver.
Al-Jiffri O, Al-Sharif F, Abd El-Kader S, Ashmawy E
Afr Health Sci. 2013; 13(3):667-72.
PMID: 24250305
PMC: 3824460.
DOI: 10.4314/ahs.v13i3.21.
Advances in the treatment of nonalcoholic fatty liver disease.
Mehta S
Ther Adv Endocrinol Metab. 2012; 1(3):101-15.
PMID: 23148155
PMC: 3475281.
DOI: 10.1177/2042018810379587.
Breakfast patterns are associated with metabolic syndrome in Korean adults.
Min C, Noh H, Kang Y, Sim H, Baik H, Song W
Nutr Res Pract. 2012; 6(1):61-7.
PMID: 22413042
PMC: 3296924.
DOI: 10.4162/nrp.2012.6.1.61.
Skipping breakfast is associated with diet quality and metabolic syndrome risk factors of adults.
Min C, Noh H, Kang Y, Sim H, Baik H, Song W
Nutr Res Pract. 2011; 5(5):455-63.
PMID: 22125684
PMC: 3221832.
DOI: 10.4162/nrp.2011.5.5.455.
Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction.
Browning J, Baker J, Rogers T, Davis J, Satapati S, Burgess S
Am J Clin Nutr. 2011; 93(5):1048-52.
PMID: 21367948
PMC: 3076656.
DOI: 10.3945/ajcn.110.007674.
